We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mount Sinai and Cleveland Clinic Say No to Aduhelm
Mount Sinai and Cleveland Clinic Say No to Aduhelm
Mount Sinai Hospital in New York and Cleveland Clinic are the latest large players in healthcare to flash a red light at Biogen’s controversial new Alzheimer’s drug Aduhelm.